Targeting NUPR1 for Cancer Treatment : A Risky Endeavor
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
NUPR1 is a transcription factor that has attracted great attention because of its various roles in cancer. Several studies were carried out to determine its molecular targets and mechanism of action to develop novel therapies against cancer. Here, we shed light on the role of NUPR1 in different types of cancer. NUPR1 regulates a complex network of pathways that may be affected by its silencing, which can cause varying effects. Its role in some types of cancer has been reported but remains incompletely understood, whereas its roles in other types of cancers have not been reported yet. Therefore, targeting NUPR1 for cancer treatment remains challenging and risky.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Current cancer drug targets - 20(2020), 10 vom: 31., Seite 768-778 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mansour, Salma M A [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.11.2021 Date Revised 22.11.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1568009620666200703152523 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311968945 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311968945 | ||
003 | DE-627 | ||
005 | 20231225143409.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1568009620666200703152523 |2 doi | |
028 | 5 | 2 | |a pubmed24n1039.xml |
035 | |a (DE-627)NLM311968945 | ||
035 | |a (NLM)32619170 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mansour, Salma M A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Targeting NUPR1 for Cancer Treatment |b A Risky Endeavor |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.11.2021 | ||
500 | |a Date Revised 22.11.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a NUPR1 is a transcription factor that has attracted great attention because of its various roles in cancer. Several studies were carried out to determine its molecular targets and mechanism of action to develop novel therapies against cancer. Here, we shed light on the role of NUPR1 in different types of cancer. NUPR1 regulates a complex network of pathways that may be affected by its silencing, which can cause varying effects. Its role in some types of cancer has been reported but remains incompletely understood, whereas its roles in other types of cancers have not been reported yet. Therefore, targeting NUPR1 for cancer treatment remains challenging and risky | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Com-1 | |
650 | 4 | |a NUPR1 | |
650 | 4 | |a cancer inhibition | |
650 | 4 | |a cancer progression | |
650 | 4 | |a chemoresistance | |
650 | 4 | |a p8 | |
650 | 4 | |a stress protein | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
650 | 7 | |a Basic Helix-Loop-Helix Transcription Factors |2 NLM | |
650 | 7 | |a NUPR1 protein, human |2 NLM | |
650 | 7 | |a Neoplasm Proteins |2 NLM | |
700 | 1 | |a Ali, Sahar A |e verfasserin |4 aut | |
700 | 1 | |a Nofal, Shaira |e verfasserin |4 aut | |
700 | 1 | |a Soror, Sameh H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current cancer drug targets |d 2001 |g 20(2020), 10 vom: 31., Seite 768-778 |w (DE-627)NLM120490560 |x 1873-5576 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2020 |g number:10 |g day:31 |g pages:768-778 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1568009620666200703152523 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2020 |e 10 |b 31 |h 768-778 |